Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 23

Trial Status

Completed2
Recruiting2

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT06340711Phase 2Recruiting
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Esophageal AdenocarcinomaGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
PrincipalinvestigatorStart date: 2024-04-25
NCT06300463Phase 2Recruiting
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
Colorectal CancerColorectal Cancer MetastaticLiver Metastases
PrincipalinvestigatorStart date: 2024-03-26
NCT05571293Phase 2Completed
Combination Immunotherapy in Colorectal Cancer
Colorectal Neoplasms
PrincipalinvestigatorStart date: 2023-03-17
NCT01386346Phase 1Completed
Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer
Esophageal CancerMalignant Neoplasm of Cardio-esophageal Junction of Stomach
PrincipalinvestigatorStart date: 2011-06-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Colorectal CancerColorectal NeoplasmsEsophageal Adenocarcinoma+2 more
Similarity Score17%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Colorectal CancerCancer of EsophagusGastric Adenocarcinoma+1 more
Similarity Score13%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Colorectal CancerColorectal Cancer MetastaticColorectal Neoplasms
Similarity Score10%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Colorectal CancerCancer of EsophagusLiver Metastases
Similarity Score10%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Colorectal CancerColorectal Cancer MetastaticColorectal Neoplasms

Worked with same sponsors:

Celgene CorporationMerck Sharp & Dohme LLC
Similarity Score10%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Colorectal CancerLiver Metastases
Similarity Score7%

Xiaoli Lan, PhD

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
16 trials

Shared therapeutic areas:

Colorectal CancerCancer of Esophagus
Similarity Score7%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Colorectal CancerLiver Metastases
Similarity Score7%

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Related
22 trials

Shared therapeutic areas:

Colorectal CancerColorectal Neoplasms
Similarity Score7%

yuankai shi, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related
17 trials

Shared therapeutic areas:

Colorectal CancerCancer of Esophagus
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06340711Phase 2PrincipalInvestigator

Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

Esophageal AdenocarcinomaGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Recruiting
NCT06300463Phase 2PrincipalInvestigator

Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases

Colorectal CancerColorectal Cancer MetastaticLiver Metastases
Recruiting
NCT05571293Phase 2PrincipalInvestigator

Combination Immunotherapy in Colorectal Cancer

Colorectal Neoplasms
Completed
NCT01386346Phase 1PrincipalInvestigator

Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer

Esophageal CancerMalignant Neoplasm of Cardio-esophageal Junction of Stomach
Completed

All 4 trials loaded